Close Menu

NEW YORK – Enzo Biochem reported after the close of the markets on Tuesday that its fiscal first quarter 2020 revenues fell 5 percent year over year, largely due to a decline in clinical services revenues.

For the three months ended Oct. 31, 2019, the company reported total revenues of $20.2 million, down from $21.3 million in the year-ago period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.